Kintegral Advisory’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.65M | Hold |
7,470
| – | – | 0.13% | 141 |
|
|
2026
Q1 | $2.21M | Sell |
7,470
-331
| -4% | -$98.3K | 0.21% | 113 |
|
|
2025
Q4 | $2.13M | Sell |
7,801
-213
| -3% | -$57.9K | 0.18% | 120 |
|
|
2025
Q3 | $2.17M | Sell |
8,014
-36
| -0.4% | -$9.79K | 0.18% | 121 |
|
|
2025
Q2 | $2.22M | Sell |
8,050
-12
| -0.1% | -$3.26K | 0.2% | 119 |
|
|
2025
Q1 | $2.14M | Sell |
8,062
-27
| -0.3% | -$6.66K | 0.22% | 119 |
|
|
2024
Q4 | $1.93M | Sell |
8,089
-377
| -4% | -$86.7K | 0.18% | 128 |
|
|
2024
Q3 | $1.87M | Sell |
8,466
-111
| -1% | -$23K | 0.17% | 134 |
|
|
2024
Q2 | $1.69M | Sell |
8,577
-1,420
| -14% | -$293K | 0.16% | 135 |
|
|
2024
Q1 | $2.15M | Sell |
9,997
-31
| -0.3% | -$6.51K | 0.22% | 110 |
|
|
2023
Q4 | $2.11M | Sell |
10,028
-64
| -0.6% | -$13.7K | 0.23% | 108 |
|
|
2023
Q3 | $2.02M | Sell |
10,092
-6
| -0.1% | -$1.19K | 0.25% | 107 |
|
|
2023
Q2 | $1.87M | Hold |
10,098
| – | – | 0.22% | 112 |
|
|
2023
Q1 | $1.93M | Sell |
10,098
-542
| -5% | -$98K | 0.25% | 111 |
|
|
2022
Q4 | $1.79M | Buy |
10,640
+548
| +5% | +$95.2K | 0.24% | 119 |
|
|
2022
Q3 | $1.79M | Hold |
10,092
| – | – | 0.25% | 102 |
|
|
2022
Q2 | $2.07M | Buy |
10,092
+214
| +2% | +$45.4K | 0.27% | 94 |
|
|
2022
Q1 | $2.35M | Buy |
9,878
+221
| +2% | +$51.9K | 0.26% | 93 |
|
|
2021
Q4 | $2.21M | Hold |
9,657
| – | – | 0.23% | 105 |
|
|
2021
Q3 | $1.87M | Hold |
9,657
| – | – | 0.22% | 108 |
|
|
2021
Q2 | $2.05M | Hold |
9,657
| – | – | 0.24% | 100 |
|
|
2021
Q1 | $1.97M | Hold |
9,657
| – | – | 0.25% | 98 |
|
|
2020
Q4 | $1.76M | Hold |
9,657
| – | – | 0.24% | 108 |
|
|
2020
Q3 | $1.62M | Sell |
9,657
-311
| -3% | -$52.4K | 0.25% | 97 |
|
|
2020
Q2 | $1.62M | Hold |
9,968
| – | – | 0.26% | 92 |
|
|
2020
Q1 | $1.72M | Buy |
9,968
+1,115
| +13% | +$222K | 0.34% | 79 |
|
|
2019
Q4 | $1.8M | Hold |
8,853
| – | – | 0.33% | 86 |
|
|
2019
Q3 | $1.87M | Hold |
8,853
| – | – | 0.37% | 78 |
|
|
2019
Q2 | $1.72M | Hold |
8,853
| – | – | 0.35% | 84 |
|
|
2019
Q1 | $1.46M | Buy |
8,853
+350
| +4% | +$61.9K | 0.31% | 94 |
|
|
2018
Q4 | $1.61M | Buy |
+8,503
| New | +$1.57M | 0.48% | 52 |
|
Other funds holding CME
Kintegral Advisory's CME Position: Q2 2026 in Review
Kintegral Advisory held its CME Group (CME) position steady in Q2 2026 at 7,470 shares worth $1.65M. The position accounts for 0.13% of the portfolio, ranked #141.
Kintegral Advisory first reported a position in CME in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.35M in Q1 2022. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Kintegral Advisory held 7,470 shares of CME Group worth $1.65M as of Q2 2026.
- Kintegral Advisory left its CME Group share count unchanged in Q2 2026.
- CME Group made up 0.13% of Kintegral Advisory's portfolio in Q2 2026, its #141 holding.
- Kintegral Advisory first reported a position in CME Group in Q4 2018 and has held it in 31 quarters since.
- Kintegral Advisory's CME Group position peaked at $2.35M in Q1 2022.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Kintegral Advisory's 13F filing for Q2 2026, filed 29 Jul 2026.